基于Notch通路探究助阳补肺除痹颗粒治疗肺纤维化的临床研究OACSTPCD
Clinical study on the treatment of pulmonary fibrosis with Zhuyang Bufei Chubi Granules based on the Notch pathway expression
目的 观察助阳补肺除痹颗粒对肺纤维化肺肾亏虚、寒瘀阻络型患者症状改善情况,患者治疗前后血液中主要炎性因子及Notch通路相关指标表达情况的影响.方法 选取肺纤维化肺肾亏虚、寒瘀阻络型患者80例,随机分为试验组与对照组,各40例,试验组给予基础治疗加助阳补肺除痹颗粒,对照组给予基础治疗加百令胶囊,2组均治疗6周.统计2组患者临床疗效,以及治疗前后呼吸困难程度状况评分、肺功能、血气分析,采集患者治疗前后血清进行相关指标检测.结果 经1个疗程治疗后,试验组总有效率为75%,对照组总有效率为55%.2组患者的临床症状、肺功能及血气分析较服药前均有所改善.治疗后患者血清中TGF-β1、TNF-α表达下降;Notch通路主要指标Notch 1、Jagged 1、Hes 1表达降低,RBP-Jκ表达升高.结论 助助阳补肺除痹颗粒可以不同程度改善肺纤维化患者临床症状,缓解呼吸困难程度,干预肺功能及血气分析,降低患者血清中TGF-β1、TNF-α含量,调节Notch 1、Jagged 1、RBP-Jκ、Hes 1的表达.
Objective To observe the effects of Zhuyang Bufei Chubi Granules on the improvement of symptoms in pulmonary fibrosis patients with the syndrome of lung and kidney deficiency,and the syndrome of cold-stasis blocking collaterals,as well as the expression of major inflammatory factors and Notch pathway related indicators in the blood of patients before and after treatment.Methods Eighty pulmonary fibrosis patients with the syndrome of lung and kidney deficiency,and the syndrome of cold-stasis blocking collaterals were selected for the study and randomly divided into an experimental group and a control group,with 40 cases in each group.The experimental group received a basic treatment plus Zhuyang Bufei Chubi Granules,while the control group received a basic treatment plus Bailing Capsules.Both groups were treated for 6 weeks.The scores of dyspnea degree,lung function,and blood gas analysis were counted in the two groups before and after treatment,and the serum samples were collected in the two groups before and after treatment for relevant indicators testing.Results The total effective rate of the experimental group with Zhuyang Bufei Chubi Granules is higher than that of the control group with Bailing Capsules.After one course of treatment,the clinical symptoms,lung function,and blood gas analysis improved in both groups compared to before medication.After treatment,the expression of TGF-β1 and TNF-α in the patients'serum was decreased,and the expression of Notch 1,Jagged 1,and Hes 1 as the main indicators of the Notch pathway was decreased,while the expression of RBP-Jκ was increased.The total effective rate was 75%in the experimental group,while the total effective rate was 55%in the control group.Conclusion Zhuyang Bufei Chubi Granules can improve the clinical symptoms in pulmonary fibrosis patients with the syndrome of lung and kidney deficiency,and the syndrome of cold-stasis blocking collaterals,relieve the degree of dyspnea,intervene in lung function and blood gas analysis,reduce the expression of TGF-β1 and TNF-α in the patients'serum,and regulate the expression of Notch 1,Jagged 1,RBP-Jκ,and Hes 1.
田治宇;仕丽;胡少丹;孙峰;曹政华
长春中医药大学,长春 130117长春中医药大学附属医院,长春 130021
中医学
助阳补肺除痹颗粒肺纤维化临床试验Notch通路
Zhuyang Bufei Chubi Granulespulmonary fibrosisclinical trialsNotch pathway
《吉林中医药》 2024 (007)
807-811 / 5
吉林省自然科学基金(YDZJ202201ZYTS236)
评论